← ANALYST RATINGS · TIPRANKS
Ovid Therapeutics (OVID): analyst forecast and price target
Analyst consensus
0 Buy0 Hold0 Sell
Ratings of 0 analysts in the last 3 months12-month forecast
Based on 0 price targets given in the last 3 months, the average target is $6.50, the highest —, the lowest —. The average is +202.3% from the last price of $2.15.
Analyst ratings 13
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 17.10.26on TipRanks 00:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 17.10.26on TipRanks 00:05 | — | |
| Rudy Li★★★★★★★★★★#235 · hits 63% · avg +76.1% | Wolfe Research | $5.00 | Buy | +132.6% | Initiated | 15.10.26on TipRanks 06:20 | +2.9%next day −3.8% | ↗ |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $2.50 → $2.00−20.0% | Hold | −7.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| Imogen Mansfield★★★★★★★★★★#4639 · hits 57% · avg +23.8% | Cantor Fitzgerald | $6.00 | Buy | +179.1% | Initiated | 09.10.26on TipRanks 06:30 | +4.5%next day −2.0% · 5 days −10.6% | ↗ |
| Laura Chico★★★★★★★★★★#527 · hits 54% · avg +14.2% | Wedbush | $7.00 | Buy | +225.6% | Reiterated | 08.10.26on TipRanks 08:35 | −0.4%next day +4.5% · 5 days −3.1% | ↗ |
| Unknown Analyst | Guggenheim | $7.00 | Buy | +225.6% | Initiated | 05.10.26on TipRanks Oct 7 00:05 | −2.4%next day +0.7% · 5 days +2.6% | ↗ |
| Ram Selvaraju★★★★★★★★★★#212 · hits 57% · avg +24.4% | H.C. Wainwright | $4.00 → $5.00+25.0% | Buy | +132.6% | Reiterated | 11.09.26on TipRanks 06:20 | +1.4%next day +2.3% · 5 days +0.1% | ↗ |
| Boobalan Pachaiyappan★★★★★★★★★★#11894 · hits 38% · avg −7.5% | Roth MKM | $8.00 | Buy | +272.1% | Reiterated | 03.09.26on TipRanks 07:10 | +1.5%next day +1.1% · 5 days −2.1% | ↗ |
| Francois Brisebois★★★★★★★★★★#2595 · hits 43% · avg +5.9% | LifeSci Capital | $5.00 | Buy | +132.6% | Reiterated | 14.08.26on TipRanks 08:35 | +1.3%next day +2.6% · 5 days +0.3% | ↗ |
| Kostas Biliouris★★★★★★★★★★#9060 · hits 41% · avg −0.1% | Oppenheimer | $9.00 | Buy | +318.6% | Reiterated | 14.08.26on TipRanks 08:15 | +1.3%next day +2.6% · 5 days +0.3% | ↗ |
| Ritu Baral★★★★★★★★★★#49 · hits 58% · avg +46.9% | TD Cowen | — | Buy | — | Reiterated | 13.08.26on TipRanks Aug 17 05:55 | +6.2%next day +1.3% · 5 days −0.2% | ↗ |
| Myles Minter★★★★★★★★★★#92 · hits 61% · avg +34.9% | William Blair | — | Buy | — | Reiterated | 13.08.26on TipRanks 14:05 | +6.2%next day +1.3% · 5 days −0.2% | ↗ |
| Madison Elsaadi★★★★★★★★★★#984 · hits 54% · avg +35.6% | B. Riley Securities | $5.00 | Buy | +132.6% | Reiterated | 13.05.26on TipRanks May 14 06:35 | −3.0%next day −0.8% · 5 days −14.5% | ↗ |
| Thomas Shrader★★★★★★★★★★#2198 · hits 39% · avg +6.6% | BTIG | $4.00 | Buy | +86.0% | Reiterated | 26.03.26on TipRanks Mar 27 07:15 | +4.3%next day −4.8% · 5 days −12.2% | ↗ |
| Marc Goodman★★★★★★★★★★#365 · hits 56% · avg +19.2% | Leerink Partners | $5.00 | Buy | +132.6% | Initiated | 17.11.25on TipRanks 06:30 | +0.5%next day +2.4% · 5 days +14.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Ovid Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $6.80 at a price of $2.49 (+173.1%); now: $6.50 at $2.15 (+202.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 11 | 7 | 5 | 6 | 10 |
| Buy | 6 | 4 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Data from the stock’s TipRanks forecast page, read 49 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗